Tirzepatide tops semaglutide for patient weight loss, study finds Grace Halsey , Richard Payerchin Key Takeaways Tirzepatide showed a 47% greater weight reduction than semaglutide in the SURMOUNT-5 trial, with significant secondary endpoint superiority
metformin For certain patients who have uncontrolled Type 2 diabetes, insulin replacement therapy might be beneficial, Burrus says
The danger comes from creating chronically excessive GH levels, which can strain the heart, underscoring the need for proper dosing and high-quality compounds
If youre researching the best peptides for weight loss, Semaglutide deserves to be at the top of your list
Some of the buzzier side effects, such as Ozempic face or Ozempic butt, are not caused by any interaction with the drug but instead are unintended weight loss consequences
[8] Liraglutide (Saxenda) also licensed for weight management in adults meeting similar BMI thresholds